Implantable insulin pumps. A position statement about their clinical use
- 6 March 2007
- journal article
- research article
- Published by Elsevier in Diabetes & Metabolism
- Vol. 33 (2) , 158-166
- https://doi.org/10.1016/j.diabet.2006.10.004
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Better long‐term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal‐time lispro insulinDiabetic Medicine, 2004
- Insulin Pump Therapy in Patients with Type 1 Diabetes Mellitus: Results of the Nationwide Quality Circle in Germany (ASD) 1999 - 2000Experimental and Clinical Endocrinology & Diabetes, 2003
- Insulin Detemir Is Associated With More Predictable Glycemic Control and Reduced Risk of Hypoglycemia Than NPH Insulin in Patients With Type 1 Diabetes on a Basal-Bolus Regimen With Premeal Insulin AspartDiabetes Care, 2003
- Effect of Intensive Therapy on the Microvascular Complications of Type 1 Diabetes MellitusJAMA, 2002
- Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.Diabetes Care, 1999
- Improvement of HbA1c and Blood Glucose Stability in IDDM Patients Treated With Lispro Insulin Analog in External PumpsDiabetes Care, 1998
- Influence of Intensive Diabetes Treatment on Quality-of-Life Outcomes in the Diabetes Control and Complications TrialDiabetes Care, 1996
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993
- Clinical Trial of Programmable Implantable Insulin Pump For Type I DiabetesDiabetes Care, 1992
- Devices for Insulin AdministrationDiabetes Care, 1990